Drugbank Logo

Search Results

Search for "Lamivudine" returned 8 results

Showing 1-8 out of 8
DrugBank ID Name Formula Weight
DB00709
DrugCard button for DB00709
Lamivudine C8H11N3O3S 229.2560
... Abacavir Sulfate) + Lamivudine + Zidovudine) Lamivudine Lamivudine is a nucleoside reverse transcriptase inhibitor (NRTI) with activity against Human Immunodeficiency Virus Type 1 (HIV-1) and ...
DB00442
DrugCard button for DB00442
Entecavir C12H15N5O3 277.2792
Entecavir is more efficient than an older Hepatitis B drug, lamivudine. Binding of entecavir to human serum proteins in vitro is approximately 13%. 153941 641041 APRD00948 entecavir Healthy ...
DB00625
DrugCard button for DB00625
Efavirenz C14H9ClF3NO2 315.6750
... infection that has not previously been treated, efavirenz and lamivudine in combination with zidovudine or tenofovir is the preferred NNRTI-based regimen. Efavirenz is also used in ...
DB00495
DrugCard button for DB00495
Zidovudine C10H13N5O4 267.2413
Combivir (Lamivudine + Zidovudine) Trizivir (Abacavir sulfate + Lamivudine + Zidovudine) Zidovudine Zidovudine is a nucleoside reverse transcriptase inhibitor (NRTI) with activity against Human ...
DB01048
DrugCard button for DB01048
Abacavir C14H18N6O 286.3323
... Abacavir Sulfate + Lamivudine) Trizivir (Abacavir Sulfate + Lamivudine + Zidovudine) Abacavir Abacavir is a nucleoside reverse transcriptase inhibitor (NRTI) with activity against Human ...
DB00718
DrugCard button for DB00718
Adefovir Dipivoxil C20H32N5O8P 501.4705
The combination of adefovir with lamivudine showed additive anti-HBV activity. ≤4% over the adefovir concentration range of 0.1 to 25 μg/mL 60871 7848718 APRD00781 ADV Adefovir Adefovir ...
DB01610
DrugCard button for DB01610
Valganciclovir C14H22N6O5 354.3617
... of reverse transcriptase inhibitors (nucleoside), such as Lamivudine, may be enhanced by Valganciclovir. There is a risk of hematologic toxicity. Diligent monitoring during concomitant therapy ...
DB00684
DrugCard button for DB00684
Tobramycin C18H37N5O9 467.5145
... of nephrotoxicity Irbesartan Increased risk of nephrotoxicity Lamivudine Increased risk of nephrotoxicity Lisinopril Increased risk of nephrotoxicity Lithium Increased risk of nephrotoxicity ...
Showing 1-8 out of 8

This project is supported by Genome Alberta & Genome Canada, a not-for-profit organization that is leading Canada's national genomics strategy with $600 million in funding from the federal government. This project is also supported in part by GenomeQuest, Inc., an enterprise genomic information company serving the life science community.